FGL1 and colorectal carcinoma: A previous study reported that FGL1 inhibits antigen-specific T-cell activation and serves as an immunosuppressive molecule for the regulation of immune homeostasis15; thus, we speculated that elevated FGL1 might mediate metastatic CRC progression through immunosuppression.